Serialization Compliance in Greece: A Guide to HMVO and Medicines Verification

 

 

Stay ahead in the fight against counterfeit medicines with our comprehensive whitepaper, Serialization Compliance in Greece: A Guide to HMVO and Medicines Verification. This resource is designed to help pharmaceutical companies understand and navigate the Hellenic Medicines Verification Organization (HMVO) complexities and comply with the Falsified Medicines Directive (FMD).

With the latest regulatory updates, the EOF code (National Drug Identification Number) is now mandatory for all medicines in Greece. Whether serialized or non-serialized, all pharmaceutical products must comply with new EOF tracking and reporting obligations, effective February 9, 2025.

 

What you’ll learn:

 

• Key serialization requirements for Greek stakeholders
• Step-by-step guide to the HMVO workflow
• Overcoming challenges in serialization and medicines verification
• Future trends in Greece’s pharmaceutical compliance landscape

 

 

Why download this guide?

 

• Ensure compliance with HMVO and the EU Hub
•  Protect patient safety and supply chain integrity
• Simplify your compliance journey with expert insights

 

 

Download your free copy now and secure your compliance success!

 

 

Download our updated whitepaper for a complete guide to the latest Greek serialization regulations, including EOF code compliance, HMVO integration, and the key changes in 2025. :